Actively Recruiting
Study of Using Optical Coherence Tomography to Analyze Inflammation in the Front Chamber of Eyes with Uveitis
Led by The Cleveland Clinic · Updated on 2026-03-04
1500
Participants Needed
1
Research Sites
52 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This research aims to explore the use of optical coherence tomography OCT scans to analyze inflammation in the front part of the eye, specifically in people with uveitis. The study is observational, meaning it observes and collects data without testing a new treatment. It investigates whether OCT can effectively image and grade the level of inflammation in eyes with both active and inactive uveitis. Participants will have OCT scans taken of the anterior chamber of their eyes to capture detailed images of inflammation. The study does not involve any treatment or intervention but focuses on gathering imaging data. This approach helps determine if OCT can be a reliable tool for assessing eye inflammation. During the study, participants will undergo the OCT imaging process, and researchers will evaluate these images to measure the degree of inflammation. The main outcome is to objectively assess inflammation levels over one year. Participants may also be asked about their ability to provide informed consent. The study is conducted over several years, allowing careful observation of inflammation patterns in uveitis.
CONDITIONS
Brief Title
Analysis of Anterior Chamber Inflammation by Optical Coherence Tomography
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients presenting to Cole Eye Institute with uveitis
You will not qualify if you...
- Unable to provide informed consent, including non-English speakers and those with cognitive or mental impairments
- Severe corneal opacities preventing imaging of the anterior chamber
Research Team
S
Sunil K Srivastava, M.D.
K
Kimberly M Baynes, BSN, RN
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here